Home/ Stocks/ CRIS

Curis Inc

CRIS XNAS

$4.02 -0.36 (-8.16%) ▼ 15-min delayed

Open

$4.35

High

$4.35

Low

$3.96

Volume

70.0K

Market Cap

$8.59M

About Curis Inc

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 24 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-24,199,000	$-1.25
FY 2025	$9.44M	$-7,582,000	$-0.58
Q3 2025	$3.18M	$-7,729,000	$-0.49
Q2 2025	$2.75M	$-8,593,000	$-0.68

Earnings & Analyst Ratings

Next Earnings: Wed, Nov 4, 2026

Calendar →

Related Market News

No specific coverage for CRIS yet. Check out our latest market news or earnings calendar.

Get CRIS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Curis Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.